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Abstract
Purpose Three compounds obtained from ephedrine were identified and characterized by various instrumental analytical 
methods. Ephedrone (methcathinone) hydrochloride and its fundamental derivatives N-acetylephedrine and N-acetylephe-
drone were analyzed as precursors of a cathinone derivative.
Methods The obtained samples were analyzed by gas chromatography coupled with mass spectrometry, nuclear magnetic 
resonance spectroscopy, infrared and Raman spectroscopy, and X-ray crystallography.
Results The three compounds were confirmed as: N-methyl-2-amino-1-phenylpropan-1-one (methcathinone) hydrochloride, 
N-acetyl-N-methyl-2-amino-1-phenylpropan-1-one (cathinone derivative), and N-acetyl-N-methyl-2-amino-1-phenylpropan-
1-ol (acetyl derivative of ephedrine).
Conclusions X-ray crystallography is especially useful for identifying the new designer drugs and their different precursor 
forms.
Keywords Methcathinone (ephedrone) · Ephedrine as synthesis precursor · X-ray crystallography · Infrared spectroscopy · 
Raman spectroscopy · NMR spectroscopy
Introduction
Ephedrone (1) is one of the oldest known synthetic cathi-
nones [1–3]. Its production has been based on ephedrine 
[(1R,2S)-1-phenyl-1-hydroxy-2-(N-methylamino)propane], 
a substance occurring naturally in shrubs of the genus 
Ephedra, native to parts of Europe, Asia, and the Americas. 
The ephedrine molecule contains two chiral carbon atoms 
and can therefore occur as four chiral isomers: two erythro 
[l-(−)-ephedrine and d-(+)-ephedrine], and two threo 
isomers [(−)-pseudoephedrine and (+)-pseudoephedrine] 
(Fig. 1). Levorotatory ephedrine occurs naturally.
Ephedrine (in general) has been listed as a drug precursor 
in Regulation No. 273/2004 of the European Parliament and 
of the Council (Annex 1).
Numerous anti-inflammatory, antipyretic, and analgesic 
drugs available over the counter contain pseudoephedrine, 
from which ephedrone can be produced at home via oxida-
tion of the partially separated component of the medica-
tion. Pseudoephedrine contained in pills is oxidized using 
potassium permanganate and an acetic acid milieu [4, 5] or, 
alternatively, using potassium dichromate in sulfuric acid 
[6]. Procedures of this type make it impossible to completely 
remove manganese or chromium ions from the mixture; 
therefore, compounds containing these elements can enter 
the human body. Literature data include reports linking the 
presence of manganese ions delivered in such a manner with 
Parkinson’s disease, possibly as a causative factor [7, 8]. 
Organic synthetic procedures for obtaining ephedrone from 
ephedrine and its analogues have also been reported [9–11].
Data concerning the crystallographic structures of ephe-
drone derivatives have been reported for metaphedrone 
hydrochloride [12], 2-MMC and 4-CMC hydrochlorides 
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[13], methylone, mephedrone, and 1-(3,4-dimethylphenyl)-
2-(methylamino)propan-1-one HCl [14]. For mephedrone 
derivatives, conditions have been specified (change of hal-
ide ion) that alter its physicochemical characteristics (phase 
transition temperatures and melting points) [15].
Despite no reported use of acetylated ephedrone deriva-
tive 3 as a designer drug, we determined the spectroscopic 
and crystallographic properties of this cathinone derivative, 
as well as those of its precursor, compound 2, which is an 
acetylated ephedrine. The apparent lack of interest in this 
compound as a designer drug may result from its poor solu-
bility in water.
Materials and methods
Deuterated dimethyl sulfoxide (DMSO-d6), deuterated 
chloroform  (CDCl3) and other chemicals were purchased 
from Sigma-Aldrich (Poznań, Poland). Melting points were 
uncorrected.
The nuclear magnetic resonance (NMR) spectra were 
recorded using an UltraShield 400 MHz apparatus (Bruker, 
Bremen, Germany) with  CDCl3 or DMSO-d6 as solvent. The 
peaks were referenced to the residual chloroform  (CHCl3; 
7.28 and 77.04 ppm) and dimethyl sulfoxide (DMSO; 2.49 
and 39.5 ppm) resonances in 1H and 13C NMR. The NMR 
data are presented in the Supplementary Material.
The infrared (IR) spectra of each compound were 
obtained using a Nicolet iS50 Fourier transform infrared 
(FTIR) spectrometer (Thermo Scientific, Warsaw, Poland) 
and the attenuated total reflectance technique. Raman meas-
urements were performed using a Thermo Scientific™ 
DXR™2xi Raman imaging microscope equipped with a 
780-nm laser (Thermo Scientific).
Gas chromatography–mass spectrometry (GC–MS) anal-
yses were performed using a Thermo Trace GC Ultra chro-
matograph coupled to a mass spectrometer (Thermo DSQ; 
Thermo Scientific). The injector was maintained at 260 °C. 
A 1-μL aliquot of the sample was injected in the splitless 
mode. Separation of sample components was conducted 
using the  Rxi®-5Sil MS column (30 m length, 0.25 mm 
inner diameter, 0.25 µm film thickness; Restek, Bellefonte, 
PA, USA). Helium was used as carrier gas at a flow rate of 
1.2 mL/min. The mass detector was set to positive electron 
ionization (EI) mode, with electron energy of 70 eV. The 
mass detector was operated in a full-scan mode in the 
40–450-amu range.
The single-crystal X-ray experiments were performed at 
100 K for compounds 1 and 3, and at 293 K for compound 
2. The data were collected using a SuperNova kappa dif-
fractometer with an Atlas charge-coupled device detector 
(Rigaku Europe, Chalgrove, UK). For the integration of the 
collected data,  CrysAlisPro software (version 1.171.38.41q, 
2015; Rigaku Europe) was used. The solving and refining 
procedures were similar for all compounds. The structures 
were solved using direct methods with SHELXS97 software, 
and the solutions were refined using SHELXL-2014/7 soft-
ware [16]. CCDC 1816306 for 1, CCDC1819495 for 2, and 
CCDC 1816307 for 3 are included in the supplementary 
crystallographic data as part of this paper. These data can 
be obtained free of charge from the Cambridge Crystallo-
graphic Data Centre ( www.ccdc.cam.ac.uk/data_reque st/
cif).
Results and discussion
Compounds 1–3 required for X-ray analysis were obtained 
from l-(−)-ephedrine hydrochloride at 5 mmol reaction 
scale, according to the scheme shown in Fig. 2. Compound 1 
was synthesized from ephedrine according to the procedure 
described in [10] and compared with the materials seized by 
drug enforcement agencies on the illicit drug market. Com-
pound 2 was obtained according to the procedure reported 
in [17]. It occurs as a mixture of two rotamers (1.1:1 ratio), 
as described previously (a 2.8:1 rotamer mixture) [18]. 
Oxidation of compound 2 was carried out in analogy with 
obtaining compound 1. Particular intermediate products 
were obtained with moderate yield (40%). Reaction efficien-
cies were not optimized. Physicochemical data pertaining 
to compounds 1 and 2 were identical with those reported 
(although compound 2 was obtained in [18] as a colorless 
liquid). Compound 3 was obtained in [17] as a colorless liq-
uid (no information was given concerning isomer type). We 
obtained all three compounds as solids, and their structures 
were corroborated by the crystallographic study.
Fig. 1  Structures of N-methyl-
2-amino-1-phenylpropan-1-one 
(ephedrone) hydrochloride (1); 
N-acetylephedrine (2), and 
N-acetyl-N-methyl-2-amino-
1-phenylpropan-1-one (N-acety-
lephedrone) (3)
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GC–MS spectra
Chromatography analyses of ephedrone have been frequently 
reported [19, 20]. The GC–MS spectra of this generated 
compound in our study were compared with those of the 
other two. These data can be helpful in analyzing other pos-
sible ephedrine derivatives. Signals from molecular ions 
of all three compounds were present at low intensities, at 
5–15%. Iminium ions (m/z = 58) were observed to be domi-
nant for all compounds. In the case of ephedrone (1), it is 
formed in a single process of bond cleavage between carbon 
atoms α and β in the side chain. In the case of compounds 
2 and 3, beside the cleavage just described above, there was 
another cleavage present (that of an acetyl group from the 
nitrogen atom). The mass spectral fragmentation patterns of 
all compounds are presented in the Supplementary Material 
(Figs. S1 and S2).
NMR spectra
The structure of compound 1 has been corroborated by 1H 
NMR and 13C NMR spectra. 1H NMR data for this com-
pound were published previously but for another solvent 
system (DMSO-d6 + D2O) [11]. For this particular solvent 
mixture, the authors observed a multiplet of benzene ring 
protons. When using pure DMSO-d6 as a solvent, particu-
lar protons were distinguished as a doublet at δ = 8.04 ppm 
(J = 8 Hz) from ortho protons, a triplet at δ = 7.76 ppm 
(J = 8 Hz) from para protons and a triplet at δ = 7.62 ppm 
(J = 8 Hz) from meta protons in the benzene ring (see Sup-
plementary Material). A similar spectrum was also reported 
in [9], although it is difficult to say whether it represented 
pure ephedrone or ephedrone hydrochloride; the lack of any 
signal from amine proton and good solubility in chloroform 
would suggest the presence of the former species. Another 
paper [21] reported two spectra identical to ours, which 
also had no NH proton signals. These spectra were obtained 
using  CDCl3 and  CD3OD. In our spectra, a broad signal of 
amine protons at δ ~ 9.25 ppm was clearly distinguishable. 
13C NMR spectra were given in [9] and [21]. Concerning [9], 
the authors provided signal shift values for all carbon atoms 
in the molecule, including that for carbonyl carbon, which 
in itself was proof of obtaining ephedrone from ephedrine. 
In [21], the signal from this carbon atom was clearly seen at 
δ = 195.22 ppm. In our study, this shift was δ = 196.8 ppm. 
The remaining signals are presented in the Supplementary 
Material.
Compound 2 occurred as two rotamers at an almost equi-
molar ratio (1.1:1 value derived from NMR spectrum). Par-
ticular protons and carbons from both rotamers displayed 
various signal shifts in 1H NMR and 13C NMR spectra, 
respectively. Aromatic protons in compound 2 occurred as 
a complex multiplet. Proton signals from the OH groups of 
both rotamers occurred adjacent to one another; the signals 
were stretched out, and their position was sample concen-
tration-dependent, as well as dependent on the presence 
of other molecules (e.g., water) in the solvent. The proton 
signals occurred at 5.43 and 5.65 ppm (see Supplementary 
Material). All the remaining protons occurred as two distinct 
signals, the ascription of which to a particular rotamer type 
can be determined by two-dimensional correlation spectros-
copy. In 13C NMR spectra, the signals of all carbon atoms 
from rotamer molecules occurred as double peaks. Such 
spectra contained only one (double) signal from the carbonyl 
group at δ = 170.0 ppm (169.7 ppm for the rotamer) in the 
acetyl moiety. Likewise, the signal from carbon in C–OH 
Fig. 2  Preparation route for 
compounds 1–3 from l-(−)-
ephedrine hydrochloride
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occurred only at δ = 75.1 ppm (74.8 ppm for the rotamer), 
which showed that no acylation of the hydroxyl group took 
place in compound 2; the possibility of obtaining an acetyl 
derivative was reported in [22, 23]. The remaining signals 
are presented in the Supplementary Material. The first 1H 
NMR spectra of compound 2 published in [17] and [24] 
did not show the presence of double signals for particular 
proton groups; it was suggested that this occurs only in the 
case of the compound’s enantiomer mixture. A subsequent 
report [25] confirmed the occurrence of rotamers in pure 
enantiomers of compound 2 and doubling of 1H NMR spec-
trum signals.
Compound 2 in solution can theoretically occur in three 
conformations, which are shown in Fig. S3 (Supplemen-
tary Material). As is obvious from crystallographic studies 
described below, the presence of conformer 2a in the crystal 
has been confirmed. Based on this knowledge and on 1H 
NMR spectral data, the other conformer present in solutions 
of this compound  was 2c. This is in accordance with ear-
lier conformational [26] and spectroscopic [27] analyses of 
ephedrine.
Compound 3 was characterized based on well-separated 
peaks from aromatic protons: a doublet at δ = 7.96 ppm 
(J = 8 Hz) from ortho protons, a triplet at δ = 7.55 ppm 
(J = 8 Hz) from para proton, and a triplet at δ = 7.44 ppm 
(J = 8 Hz) from meta protons of the benzene ring. The lack 
of signal from amine group protons confirmed its acylation. 
The peak of C–H proton was strongly shifted (δ = 6.15 ppm). 
The 13C NMR spectrum was characterized by the presence 
of signals from two carbonyl carbon atoms: one presented 
in an amide group (δ = 170.4 ppm) and the other in Ar–CO 
(δ = 199.3  ppm). The remaining peaks occurred in the 
expected positions.
IR and Raman spectra
IR and Raman spectra can be useful for characterizing the 
synthesis of designer drugs. Spectral analysis of mixtures 
can reveal much information about particular stages of 
synthesis. In the case of ephedrone and its derivatives syn-
thesized from ephedrine, pseudoephedrine or their deriva-
tives (e.g., acetylated derivatives), characteristic vibrations 
of ketone or hydroxyl groups allowed the assessment of a 
putative route of synthesis for an examined compound. FTIR 
and Raman FT spectra of compound 1 were reported in [21]. 
These spectra are identical with those (denoted as Figs. S4 
and S7) generated in our study, and presented together with 
spectra of compounds 2 (Figs. S5 and S8) and 3 (Figs. S6 
and S9), respectively (see Supplementary Material).
Vibrations of the carbonyl group from a propionic frag-
ment occurred in similar positions in the FTIR spectra of 
compounds 1 and 3 (1687 and 1688 cm−1, respectively). 
Compound 3  had yet another carbonyl group vibrational 
band at 1629 cm−1, originating from this compound’s acetyl 
moiety. The spectrum of compound 2 featured one strong 
vibrational CO band from an acetyl fragment at 1602 cm−1, 
as well as a very strong band at 3275 cm−1, characteristic of 
vibrations of OH.
In the Raman spectra of compounds 1–3, the most char-
acteristic were C=O and aromatic ring vibrations. The C=O 
absorptions appeared at 1686 cm−1 for 1, at 1603 cm−1 for 
2, and at 1686 cm−1 and 1628 cm−1 for 3. The aromatic ring 
vibrations appeared at 1597, 1580, and 1596 cm−1 for com-
pounds 1–3, respectively.
X‑ray analysis
The salt 1 was crystallized from DMSO solution as colorless 
plate-like crystals. Compound 2 was crystallized from water, 
also as colorless plate-like crystals. Compound 3 was crys-
tallized from chloroform solution as colorless needle-shaped 
crystals. The crystal structures of compound 1 are shown in 
Fig. 3 (crystal structures for 2 and 3 are shown in Figs. S10 
and S11, whereas crystal packing is shown in Figs. S14 and 
S15, respectively). Crystal data and structure refinement for 
compounds 1–3 are presented in Table 1.
Both cathinones 1 and 3 occurred as expected S-isomers, 
which was in accordance with the mechanism of their for-
mation from l-(−)-ephedrine. Both molecules crystallized 
in orthorhombic space groups. In the crystallographic 
structure of compound 1, an important role was assigned 
to the N–H···Cl− hydrogen bonds. The N–H donors (from 
 R1R2NH2+ groups) donated the hydrogen bonds to chloride 
anions separated from one another by a distance of 2.166 to 
2.280 Å, with N–H···Cl− angles from 147.89° to 157.32°. 
The separation of N···Cl− was between 3.017 and 3.089 
Å. Distances and angles listed above were similar to those 
reported in [28]. Analysis of crystal packing in compound 1 
revealed much empty space between molecules, especially 
considering the packing along the b axis of the elementary 
cell (Fig. 4). The schemes of crystal packing along other 
axes are presented in Figs. S12 and S13. Crystal packing for 
compounds 2 and 3 is shown only along the b axis in Figs. 
S14 and S15, respectively.
N-Acetylephedrine (2) crystal which we managed to 
obtain from aqueous solution contained  only one kind of 
conformer in the elementary cell. No other conformer was 
found to be present in solution, and this was corroborated 
by NMR spectra, both in this study and in [24, 25]. The 
hydroxyl group in compound 2 played  a fundamental role in 
the arrangement of particular molecular fragments relative to 
one another, which is likely of importance to the packing of 
molecules in the elementary cell. The presence of an intra-
molecular C9–H···O1 hydrogen bond of 2.503 Å could be 
noted, although the D–H···A angle  was only 123.39°, along 
with an intermolecular hydrogen bond between the OH 
228 Forensic Toxicology (2019) 37:224–230
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group of one molecule and the oxygen atom from an adja-
cent acetyl group (length 1.989 Å, angle D–H···A 171.15°). 
The positioning of the phenyl ring with respect to the mol-
ecule’s skeleton may be stabilized by a weak hydrogen bond 
 CAr–H···OH (length 2.625 Å, angle D–H···A—140.56°), as 
well as with a C–H···Arcentr bond (length 2.684 Å, angle 
D–H···A—143.88°). The characterized crystal of compound 
2 featured  conformer 2a (Fig. S17). No other stable con-
formers could be confirmed in the examined crystal.
Compound 2’s conformation was “forced” by the occur-
rence of weak hydrogen bonds between oxygen atoms (O1 
and O2) and hydrogen atoms from methyl groups at the 
C9 nitrogen and C12 carbon. All distances which could be 
determined between hydrogen atoms and their acceptors 
(oxygen atoms)  were shorter (2.246, 2.503 and 2.551 Å) 
than the sum of the van der Waals radii for these elements 
(2.72 Å) (Fig. S18).
The crystallographic structure of compound 3 differed 
significantly from that of compound 2. Due to the lack of 
an ionized fragment in the molecule, which would facilitate 
its solubility in water, it also lacked  strong intermolecular 
hydrogen bonds. The acetamide fragment  was planar with 
an almost ideal  Nsp2 atom. This fragment existed in the 
mesomeric form characteristic for peptide bonds, in which 
a single bond occurs between C and O atoms and a double 
bond between C and N atoms.
Weak hydrogen bonds occurred between oxygen atoms 
from carbonyl groups (both at C7 atom and in acetyl sub-
stituent; Fig. S16 in Supplementary Material) and protons 
from adjacent molecules. One can also find a few weak intra-
molecular hydrogen bonds which stabilize a characteristic 
bend of the benzene ring with respect to the plane of the 
amide fragment (see Supplementary Material).
Conclusions
Ephedrone, which is easily made at home from legally 
available drugs, may be among the most frequently abused 
designer narcotics. Methods of obtaining this harmful com-
pound are available on the web. Despite straightforward 
synthesis, the end product is contaminated with manganese 
ions, believed to be involved in the development of drug-
induced parkinsonism. Spectroscopic and crystallographic 
data concerning ephedrone and its acetylated derivatives 
could be helpful in assessing evidence in criminal proceed-
ings. The NMR spectra of compound 2 suggest the exist-
ence of two stable conformers of this compound in solution, 
although the crystallographic structure determined during 
Fig. 3  (S)-Enantiomer molecule 
of compound 1 in the crystal. 
Ellipsoids for non-H atoms 
correspond to 50% probability 
levels
Fig. 4  Packing diagram for 1: 
view along the b axis
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analysis of aqueous solution-derived crystals demonstrated 
the presence of only one type of conformer.
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